Apotex's importation of Chantix (varenicline) and Express Scripts' formulary exclusions were among the best read articles this year that didn't concern COVID-19.
This is the first approval of generic version of Chantix, and it comes just weeks after a recall of the brand-name drug.
This is being done in coordination with the FDA to address the shortage created by the recall of Chantix.
Four products on the preferred list this year will be excluded next year.
Anjeso, a COX-2 inhibito, is a faster-acting injectable formulation of meloxicam. As amnm alternative to opiods, it reduces opioid use after surgery.
Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin.